FDA.reportPublic FDA data

Nulibry 9.5 MG Injection

RxCUI
2531297
RxNorm name
Nulibry 9.5 MG Injection
Display name
Nulibry 9.5 MG Injection
Full name
Nulibry 9.5 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NulibryFOSDENOPTERIN HYDROBROMIDESentynl Therapeutics, Inc.736aeea3-f206-454d-95d0-fd30964e8aab2026-05-26Warnings, Adverse reactionsExact identifier
rxcui: 2531297

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
736aeea3-f206-454d-95d0-fd30964e8aabNulibry 9.5 MG Injection [PSN] · fosdenopterin 9.5 MG Injection [Nulibry] [SBD] · Nulibry 9.5 MG Injection [SY]33These highlights do not include all the information needed to use NULIBRY ® safely and effectively. See full prescribing information for NULIBRY. NULIBRY (fosdenopterin) for injection, for intravenous use Initial U.S. Approval: 202120221028